Illumina MiSeq Instrument Service Agreement
SAM.GOV Due: April 30, 2025 at 06:00 PM UTC
In-Active Sources Sought Source Url

Summary

The U.S. Food and Drug Administration (FDA) is conducting market research to identify potential contractors for a service agreement related to the Illumina MiSeq instrument, specifically for preventative and corrective maintenance. This opportunity is aimed at small businesses capable of providing comprehensive maintenance services, including scheduled on-site visits, unlimited technical support, and adherence to OEM specifications. Contractors should be equipped to handle both preventative maintenance and urgent repairs, ensuring the instrument's reliability for ongoing research at the National Center for Toxicological Research (NCTR). Interested businesses should demonstrate their capability to meet these requirements and are encouraged to submit capability statements by the specified deadline.
Description

MARKET RESEARCH PURPOSES ONLY

NOT A REQUEST FOR PROPOSAL OR SOLICITATION

The U.S. Food and Drug Administration (FDA) is conducting market research to support the National Center for Toxicological Research (NCTR) requirement for a preventative main

Entities
HAHSDO
Department of Health and Human Services
FADA
Food and Drug Administration
NAICS
811210
Set Aside
None
Place of Performance
Jefferson , Arkansas 72079
Point of Contact
Full Name Email Phone Type
Nick Sartain [email protected] 8705437370 primary